로딩 중…
지수 로딩 중…
SCL Science Inc.
246960· KOSDAQ· Health Care· Health Care Equipment & Services
₩1,702-4.60%
2026-06-19
Price Chart
SCL Science Inc.-37.24%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 57.90B KRW |
| Revenue | 27.40B KRW |
| Net Income | -3.50B KRW |
| Total Assets | 77.44B KRW |
| Net Assets | 22.51B KRW |
| Employees | 63 |
| Value | |
| P/B | 2.57x |
| P/S | 2.11x |
| FCF Yield | -5.26% |
| Profitability | |
| ROE | -15.53% |
| ROA | -4.51% |
| Op. Margin | -9.84% |
| Revenue Growth | 237.88% |
| Financial Health | |
| Debt Ratio | 343.96% |
| Total Debt | 25.45B KRW |
| FCF | -3.05B KRW |
| Cash | 2.66B KRW |
| Current Ratio | 0.90x |
| Performance | |
| 1Y Return | -37.24% |
| 1M Return | -6.59% |
| From 52W High | -66.69% |
| 1Y MDD | -58.61% |
| Trading | |
| Volume | 68,475 shares |
| Foreign Own. | 0.63% |
| Per Share | |
| EPS | -93 KRW |
| BPS | 694 KRW |
Company Info
SCL Science, established in 2010 and listed on KOSDAQ in 2019, is a bio venture company. It primarily develops and produces medical hemostatic agents using biomimetic technology inspired by mussel adhesion, alongside operating bio-logistics and data platform-based digital healthcare businesses. The company is developing a range of hemostatic products applicable to patients with blood coagulation disorders and expanding its product portfolio with polymer modification technology, growing into a healthcare company. SCL Science is headquartered in Yeongdeungpo-gu, Seoul.